Global Antidiabetics Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 95

Report ID: 6370

Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.

The global Antidiabetics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antidiabetics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antidiabetics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Other

Segment by Application
Hospital Use
Clinic Use
Household
Other

Table of Contents

Executive Summary
1 Antidiabetics Market Overview
1.1 Product Overview and Scope of Antidiabetics
1.2 Antidiabetics Segment by Type
1.2.1 Global Antidiabetics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.2.4 Other
1.3 Antidiabetics Segment by Application
1.3.1 Antidiabetics Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Antidiabetics Market by Region
1.4.1 Global Antidiabetics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Antidiabetics Market Size
1.5.1 Global Antidiabetics Revenue (2014-2025)
1.5.2 Global Antidiabetics Production (2014-2025)

2 Global Antidiabetics Market Competition by Manufacturers
2.1 Global Antidiabetics Production Market Share by Manufacturers (2014-2019)
2.2 Global Antidiabetics Revenue Share by Manufacturers (2014-2019)
2.3 Global Antidiabetics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Antidiabetics Production Sites, Area Served, Product Types
2.5 Antidiabetics Market Competitive Situation and Trends
2.5.1 Antidiabetics Market Concentration Rate
2.5.2 Antidiabetics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Antidiabetics Production Market Share by Regions
3.1 Global Antidiabetics Production Market Share by Regions
3.2 Global Antidiabetics Revenue Market Share by Regions (2014-2019)
3.3 Global Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Antidiabetics Production
3.4.1 North America Antidiabetics Production Growth Rate (2014-2019)
3.4.2 North America Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Antidiabetics Production
3.5.1 Europe Antidiabetics Production Growth Rate (2014-2019)
3.5.2 Europe Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Antidiabetics Production (2014-2019)
3.6.1 China Antidiabetics Production Growth Rate (2014-2019)
3.6.2 China Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Antidiabetics Production (2014-2019)
3.7.1 Japan Antidiabetics Production Growth Rate (2014-2019)
3.7.2 Japan Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Antidiabetics Consumption by Regions
4.1 Global Antidiabetics Consumption by Regions
4.2 North America Antidiabetics Consumption (2014-2019)
4.3 Europe Antidiabetics Consumption (2014-2019)
4.4 China Antidiabetics Consumption (2014-2019)
4.5 Japan Antidiabetics Consumption (2014-2019)

5 Global Antidiabetics Production, Revenue, Price Trend by Type
5.1 Global Antidiabetics Production Market Share by Type (2014-2019)
5.2 Global Antidiabetics Revenue Market Share by Type (2014-2019)
5.3 Global Antidiabetics Price by Type (2014-2019)
5.4 Global Antidiabetics Production Growth by Type (2014-2019)

6 Global Antidiabetics Market Analysis by Applications
6.1 Global Antidiabetics Consumption Market Share by Application (2014-2019)
6.2 Global Antidiabetics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Antidiabetics Business
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Antidiabetics Production Sites and Area Served
7.1.2 Antidiabetics Product Introduction, Application and Specification
7.1.3 Sanofi-Aventis Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Takeda Pharmaceuticals
7.2.1 Takeda Pharmaceuticals Antidiabetics Production Sites and Area Served
7.2.2 Antidiabetics Product Introduction, Application and Specification
7.2.3 Takeda Pharmaceuticals Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Eli Lilly
7.3.1 Eli Lilly Antidiabetics Production Sites and Area Served
7.3.2 Antidiabetics Product Introduction, Application and Specification
7.3.3 Eli Lilly Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Oramed Pharmaceuticals
7.4.1 Oramed Pharmaceuticals Antidiabetics Production Sites and Area Served
7.4.2 Antidiabetics Product Introduction, Application and Specification
7.4.3 Oramed Pharmaceuticals Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Antidiabetics Production Sites and Area Served
7.5.2 Antidiabetics Product Introduction, Application and Specification
7.5.3 Boehringer Ingelheim Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Antidiabetics Production Sites and Area Served
7.6.2 Antidiabetics Product Introduction, Application and Specification
7.6.3 Merck & Co. Inc. Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Novo Nordisk
7.7.1 Novo Nordisk Antidiabetics Production Sites and Area Served
7.7.2 Antidiabetics Product Introduction, Application and Specification
7.7.3 Novo Nordisk Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Antidiabetics Production Sites and Area Served
7.8.2 Antidiabetics Product Introduction, Application and Specification
7.8.3 Bristol-Myers Squibb Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Halozyme Therapeutics
7.9.1 Halozyme Therapeutics Antidiabetics Production Sites and Area Served
7.9.2 Antidiabetics Product Introduction, Application and Specification
7.9.3 Halozyme Therapeutics Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Pfizer
7.10.1 Pfizer Antidiabetics Production Sites and Area Served
7.10.2 Antidiabetics Product Introduction, Application and Specification
7.10.3 Pfizer Antidiabetics Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 Antidiabetics Manufacturing Cost Analysis
8.1 Antidiabetics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Antidiabetics
8.4 Antidiabetics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Antidiabetics Distributors List
9.3 Antidiabetics Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Antidiabetics Market Forecast
11.1 Global Antidiabetics Production, Revenue Forecast
11.1.1 Global Antidiabetics Production Growth Rate Forecast (2019-2025)
11.1.2 Global Antidiabetics Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Antidiabetics Price and Trend Forecast (2019-2025)
11.2 Global Antidiabetics Production Forecast by Regions (2019-2025)
11.2.1 North America Antidiabetics Production, Revenue Forecast (2019-2025)
11.2.2 Europe Antidiabetics Production, Revenue Forecast (2019-2025)
11.2.3 China Antidiabetics Production, Revenue Forecast (2019-2025)
11.2.4 Japan Antidiabetics Production, Revenue Forecast (2019-2025)
11.3 Global Antidiabetics Consumption Forecast by Regions (2019-2025)
11.3.1 North America Antidiabetics Consumption Forecast (2019-2025)
11.3.2 Europe Antidiabetics Consumption Forecast (2019-2025)
11.3.3 China Antidiabetics Consumption Forecast (2019-2025)
11.3.4 Japan Antidiabetics Consumption Forecast (2019-2025)
11.4 Global Antidiabetics Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Antidiabetics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer